How do leading gastroenterologists manage the most challenging Barrett’s esophagus cases?
Raising the Barrx™ is here to answer that question across a series of digestible 20-minute podcasts.


Barrett’s endotherapy can get complicated. But the more we discuss these cases, the more we enhance clinical practice.

From preventing and treating post-treatment strictures, to deciding when not to rush into ablation, to debating how patients should be monitored post-eradication, Raising the Barrx™ tackles the topics that shape your everyday decision-making. 


Gain valuable knowledge from renowned EU gastroenterologists.

Discover the latest Barrx™ RFA clinical findings.

Understand how Barrx™ RFA can improve patient outcomes.



EPISODE 1

Complex cases and how to manage them


Host: Dr. Rehan Haidry
Expert panel: Prof. Max Barret, Prof. Raf Bisschops, Prof. José Miguel Esteban


Listen for discussions on:

  • Tips and tricks for managing difficult strictures
  • How to treat large hiatal hernias
  • Patient care post-eradication

 


EPISODE 2

A deep dive into radiofrequency ablation


Host: Dr. David Graham
Expert panel: Prof. John Morris, Prof. Jacques Bergman, Dr. Rehan Haidry


Listen for discussions on:

  • Patient selection, treatment, and outcomes
  • Evidence and technique
  • 360 and focal devices

 


EPISODE 3

Using radiofrequency beyond Barrett’s esophagus


Host: Dr. David Graham
Expert panel: Dr. Rehan Haidry, Prof. Marine Camus, Dr. Jason Dunn

Listen for discussions on:

  • Gastric antral vascular ectasia
  • Squamous dysplasia
  • Inlet patches

 





Learn more about Barrx™

The Barrx™ radiofrequency ablation system is indicated for the coagulation of bleeding and non-bleeding sites in the gastrointestinal tract including, but not limited to, Barrett’s esophagus.






Medtronic is committed to improving patient care through education and innovation. We’re delighted to share this series with you; we look forward to your participation and welcome your feedback. Please get in touch via the form below.